Literature DB >> 28070874

Infection of defective human T-lymphotropic virus type 1.

Yuuki Hashikura1, Kazumi Umeki1, Kunihiko Umekita1, Hajime Nomura1, Akiteru Yamada1, Ikuo Yamamoto1, Hiroo Hasegawa2, Katsunori Yanagihara2, Akihiko Okayama3.   

Abstract

In a previous study, we reported that an identical defective provirus had integrated into multiple sites of the genome of a representative human T-lymphotropic virus type 1 (HTLV-1) cell line, MT-2. A possible explanation for this may be the repeated infection of this defective provirus to a cell. Therefore, we attempted to determine whether a defective provirus could transmit during the co-culture of HTLV-1 uninfected human T-cell line, Jurkat, with MT-2 cells treated with mitomycin C. As a result, we established not only a cell line with the integration of one complete provirus, but also a cell line with the integration of one defective provirus. The rearrangement of the T-cell receptor -γ gene of these cell lines showed them to be derived from Jurkat cells. Both HTLV-1 Tax/Rex and HBZ RNA were detected in the cell line, which harbors a complete provirus. On the other hand, HBZ RNA and transcriptional product specific for the defective provirus were detected in the cell line, which harbors a defective HTLV-1 provirus only. These results suggested that a defective HTLV-1 provirus with large depletion of internal sequence could transmit to other cells. Moreover, the defective provirus can be transcriptionally active. This suggested the possibility that the defective HTLV-1 provirus found in the lymphocytes of HTLV-1 carriers and patients with adult T-cell leukemia may transmit to other T-cells in vivo. The results also suggested that defective provirus in HTLV-1 carriers could be functional and may play a role in leukemogenesis.

Entities:  

Keywords:  Defective virus; HTLV-1; MT-2 cell line

Mesh:

Substances:

Year:  2017        PMID: 28070874     DOI: 10.1007/s13577-016-0156-4

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  29 in total

1.  Structural analysis of p28 adult T-cell leukaemia-associated antigen.

Authors:  T Iino; K Takeuchi; S H Nam; H Siomi; H Sabe; N Kobayashi; M Hatanaka
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

2.  Can viruses form biofilms?

Authors:  Maria-Isabel Thoulouze; Andrés Alcover
Journal:  Trends Microbiol       Date:  2011-03-31       Impact factor: 17.079

3.  Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.

Authors:  Tadahiko Igakura; Jane C Stinchcombe; Peter K C Goon; Graham P Taylor; Jonathan N Weber; Gillian M Griffiths; Yuetsu Tanaka; Mitsuhiro Osame; Charles R M Bangham
Journal:  Science       Date:  2003-02-13       Impact factor: 47.728

4.  Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.

Authors:  K Etoh; S Tamiya; K Yamaguchi; A Okayama; H Tsubouchi; T Ideta; N Mueller; K Takatsuki; M Matsuoka
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

5.  HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.

Authors:  Yorifumi Satou; Jun-ichirou Yasunaga; Mika Yoshida; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

6.  Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.

Authors:  K Tsukasaki; H Tsushima; M Yamamura; T Hata; K Murata; T Maeda; S Atogami; H Sohda; S Momita; S Ideda; S Katamine; Y Yamada; S Kamihira; M Tomonaga
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

7.  Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.

Authors:  Shiro Ueno; Kazumi Umeki; Ichiro Takajo; Yasuhiro Nagatomo; Norio Kusumoto; Kunihiko Umekita; Kazuhiro Morishita; Akihiko Okayama
Journal:  Int J Cancer       Date:  2011-08-29       Impact factor: 7.396

8.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

9.  The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.

Authors:  Yuuki Hashikura; Kazumi Umeki; Kunihiko Umekita; Hajime Nomura; Ikuo Yamamoto; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama
Journal:  Hum Cell       Date:  2016-03-03       Impact factor: 4.174

10.  Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.

Authors:  Maki Miyazaki; Jun-Ichirou Yasunaga; Yuko Taniguchi; Sadahiro Tamiya; Tatsutoshi Nakahata; Masao Matsuoka
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

View more
  2 in total

1.  Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of in vitro human cells by viral infection.

Authors:  Setsuko Shioda; Fumio Kasai; Ken Watanabe; Kohei Kawakami; Azusa Ohtani; Masashi Iemura; Midori Ozawa; Akemi Arakawa; Noriko Hirayama; Eiko Kawaguchi; Tomoko Tano; Sayaka Miyata; Motonobu Satoh; Norio Shimizu; Arihiro Kohara
Journal:  R Soc Open Sci       Date:  2018-05-02       Impact factor: 2.963

2.  Provirus Mutations of Human T-Lymphotropic Virus 1 and 2 (HTLV-1 and HTLV-2) in HIV-1-Coinfected Individuals.

Authors:  Karoline Rodrigues Campos; Adele Caterino-de-Araujo
Journal:  mSphere       Date:  2020-09-30       Impact factor: 4.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.